108 related articles for article (PubMed ID: 17920554)
1. A spectrophotometric assay for histone deacetylase 8.
Fatkins DG; Zheng W
Anal Biochem; 2008 Jan; 372(1):82-8. PubMed ID: 17920554
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases.
Schultz BE; Misialek S; Wu J; Tang J; Conn MT; Tahilramani R; Wong L
Biochemistry; 2004 Aug; 43(34):11083-91. PubMed ID: 15323567
[TBL] [Abstract][Full Text] [Related]
3. Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation.
Fatkins DG; Monnot AD; Zheng W
Bioorg Med Chem Lett; 2006 Jul; 16(14):3651-6. PubMed ID: 16697640
[TBL] [Abstract][Full Text] [Related]
4. A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening.
Ciossek T; Julius H; Wieland H; Maier T; Beckers T
Anal Biochem; 2008 Jan; 372(1):72-81. PubMed ID: 17868634
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of a novel human histone deacetylase, HDAC8.
Buggy JJ; Sideris ML; Mak P; Lorimer DD; McIntosh B; Clark JM
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):199-205. PubMed ID: 10926844
[TBL] [Abstract][Full Text] [Related]
6. Development of a scintillation proximity assay for histone deacetylase using a biotinylated peptide derived from histone-H4.
Nare B; Allocco JJ; Kuningas R; Galuska S; Myers RW; Bednarek MA; Schmatz DM
Anal Biochem; 1999 Feb; 267(2):390-6. PubMed ID: 10036146
[TBL] [Abstract][Full Text] [Related]
7. Development and optimization of a binding assay for histone deacetylase 4 using surface plasmon resonance.
Mattu M; Di Giovine P; Steinkuhler C; De Francesco R; Altamura S; Cecchetti O; Carfì A; Barbato G
Anal Biochem; 2008 Jun; 377(2):267-9. PubMed ID: 18381195
[TBL] [Abstract][Full Text] [Related]
8. A miniaturized readout strategy for endogenous histone deacetylase activity.
Jost JO; Hanswillemenke A; Schwarzer D
Mol Biosyst; 2015 Jul; 11(7):1820-3. PubMed ID: 26009008
[TBL] [Abstract][Full Text] [Related]
9. A mechanism-based inactivator for histone demethylase LSD1.
Culhane JC; Szewczuk LM; Liu X; Da G; Marmorstein R; Cole PA
J Am Chem Soc; 2006 Apr; 128(14):4536-7. PubMed ID: 16594666
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
11. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 8 in neuroblastoma tumorigenesis.
Oehme I; Deubzer HE; Wegener D; Pickert D; Linke JP; Hero B; Kopp-Schneider A; Westermann F; Ulrich SM; von Deimling A; Fischer M; Witt O
Clin Cancer Res; 2009 Jan; 15(1):91-9. PubMed ID: 19118036
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction.
Marcotte PA; Richardson PL; Guo J; Barrett LW; Xu N; Gunasekera A; Glaser KB
Anal Biochem; 2004 Sep; 332(1):90-9. PubMed ID: 15301953
[TBL] [Abstract][Full Text] [Related]
14. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylases as transducers and targets of nuclear signaling.
Walkinshaw DR; Tahmasebi S; Bertos NR; Yang XJ
J Cell Biochem; 2008 Aug; 104(5):1541-52. PubMed ID: 18425769
[TBL] [Abstract][Full Text] [Related]
17. N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine.
Jamonnak N; Fatkins DG; Wei L; Zheng W
Org Biomol Chem; 2007 Mar; 5(6):892-6. PubMed ID: 17340003
[TBL] [Abstract][Full Text] [Related]
18. Optimization of a series of potent and selective ketone histone deacetylase inhibitors.
Pescatore G; Kinzel O; Attenni B; Cecchetti O; Fiore F; Fonsi M; Rowley M; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2008 Oct; 18(20):5528-32. PubMed ID: 18809328
[TBL] [Abstract][Full Text] [Related]
19. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination.
Boyault C; Sadoul K; Pabion M; Khochbin S
Oncogene; 2007 Aug; 26(37):5468-76. PubMed ID: 17694087
[TBL] [Abstract][Full Text] [Related]
20. Reticulon RTN1-C(CT) peptide: a potential nuclease and inhibitor of histone deacetylase enzymes.
Nepravishta R; Bellomaria A; Polizio F; Paci M; Melino S
Biochemistry; 2010 Jan; 49(2):252-8. PubMed ID: 20000484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
